During the past decade, Ziekenhuis St. Jansdal conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 7 clinical trials were completed, i.e. on average, 25.9% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 4 clinical trials were completed. i.e. 22.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ziekenhuis St. Jansdal" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 7 trials, followed by "Radboud University Medical Center" with 5 trials sponsored, "Dutch Colorectal Cancer Group" with 3 trials sponsored, "Amgen" with 2 trials sponsored and "Boehringer Ingelheim" with 2 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ziekenhuis St. Jansdal" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "ZonMw: The Netherlands Organisation for Health Research and Development" with 3 trials as a collaborator, "Borstkanker Onderzoek Groep" with 2 trials as a collaborator, "Roche Pharma AG" with 2 trials as a collaborator and "ALMANAC Trialists Group" with 1 trials as a collaborator. Other collaborators include 76 different institutions and companies that were collaborators in the rest 86 trials.

According to Clinical.Site data, the most researched conditions in "Ziekenhuis St. Jansdal" are "Breast Cancer" (5 trials), "Carcinoma, Non-Small-Cell Lung" (4 trials), "Lung Cancer" (4 trials), "Colorectal Cancer" (3 trials) and "Heart Failure" (3 trials). Many other conditions were trialed in "Ziekenhuis St. Jansdal" in a lesser frequency.

Most popular intervention types in "Ziekenhuis St. Jansdal" are "Drug" (32 trials), "Device" (4 trials), "Other" (4 trials), "Procedure" (4 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Carboplatin" (4 trials), "Pemetrexed" (4 trials), "Cisplatin" (3 trials) and "cisplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Ziekenhuis St. Jansdal" are 39 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Ziekenhuis St. Jansdal". 1 are not yet recruiting, 9 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Ziekenhuis St. Jansdal, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Ziekenhuis St. Jansdal, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 6 trials that are defined as “Not Applicable".